Granules India Ltd GRANULES
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 406.75
- Day Range
- INR 403.20–408.00
- 52-Week Range
- INR 272.35–480.45
- Bid/Ask
- INR 406.75 / INR 407.00
- Market Cap
- INR 98.58 Bil
- Volume/Avg
- 169,373 / 1.1 Mil
Key Statistics
- Price/Earnings (Normalized)
- 23.45
- Price/Sales
- 2.15
- Dividend Yield (Trailing)
- 0.38%
- Dividend Yield (Forward)
- 0.38%
- Total Yield
- 0.38%
Company Profile
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages. Its business is organized into three areas; the Core business which comprises core molecules such as Paracetamol, Ibuprofen, Metformin, Guaifenesin, and Methocarbamol; the Emerging business that focuses on manufacturing APIs and the US Generics. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and Rest of World.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 5,873
- Website
- https://www.granulesindia.com
Comparables
Valuation
|
Metric
|
GRANULES
|
DIVISLAB
|
500288
|
|---|---|---|---|
Price/Earnings (Normalized) | 23.45 | 73.90 | 31.56 |
Price/Book Value | 3.01 | 8.19 | 3.07 |
Price/Sales | 2.15 | 14.04 | 1.47 |
Price/Cash Flow | 16.63 | 67.42 | 29.93 |
Price/Earnings
GRANULES
DIVISLAB
500288
Financial Strength
|
Metric
|
GRANULES
|
DIVISLAB
|
500288
|
|---|---|---|---|
Quick Ratio | 0.66 | 5.54 | 0.95 |
Current Ratio | 1.40 | 8.79 | 2.23 |
Interest Coverage | 6.17 | 5,189.00 | 30.56 |
Quick Ratio
GRANULES
DIVISLAB
500288
Profitability
|
Metric
|
GRANULES
|
DIVISLAB
|
500288
|
|---|---|---|---|
Return on Assets (Normalized) | 7.94% | — | — |
Return on Equity (Normalized) | 13.83% | — | — |
Return on Invested Capital (Normalized) | 11.52% | — | — |
Return on Assets
GRANULES
DIVISLAB
500288
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Hszgpsmzc | Rnykr | $79.4 Bil | |
MKKGY
| Merck KGaA ADR | Rtvrxvqw | Hxwbsj | $79.0 Bil | |
HLN
| Haleon PLC ADR | Vrtdygj | Nfsg | $38.5 Bil | |
VTRS
| Viatris Inc | Pbdcwgbh | Dmmwn | $13.1 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Vyvzcsty | Tvhn | $11.7 Bil | |
CTLT
| Catalent Inc | Wdnzfkfk | Fzlgjr | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Tpdhpcfkt | Jnfrc | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Gxkbftmzl | Brsdg | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Pvgrqqg | Ljnrvym | $3.2 Bil | |
GTBIF
| Green Thumb Industries Inc | Mpkfylqcnp | Xfft | $3.1 Bil |